Northeast Florida Medicine Journal, Winter 2015

59 / 78

DCMS online. org Northeast Florida Medicine Vol. 66, No. 4 2015 59
CME
References
1. Peppercorn MA, Kane SV. Clinical manifestations, diag-
nosis, and prognosis of ulcerative colitis/ Crohn’s disease
in adults [Internet]. Waltham (MA); 2015 Sept. Available
from:
2. Feldman M, Friedman LS, Brandt LJ. Sleisenger and
Fordtran’s Gastrointestinal and Liver Disease: Pathophys-
iology, Diagnosis, Management. 9th ed. Philadelphia:
Saunders, Elsevier; c2010.
3. Bernstein CN, Leslie WD, Leboff MS. AGA technical
review on osteoporosis in gastrointestinal diseases. Gas-
troenterology. 2003 Mar;124(3):795-841.
4. van Hogezand RA, Hamdy NA. Skeletal morbidity in
inflammatory bowel disease. Scand J Gastroenterol Suppl.
2006;(243):59-64.
5. Abitbol V, Roux C, Chaussade S, et al. Metabolic bone
assessment in patients with inflammatory bowel disease.
Gastroenterology. 1995 Feb;108(2):417-22.
6. Ali T, Lam D, Bronze MS, Humphrey MB. Osteopo-
rosis in inflammatory bowel disease. Am J Med. 2009
Jul;122(7):599-604.
7. Maunder RG, Levenstein S. The role of stress in the
development and clinical course of inflammatory bowel
disease: epidemiological evidence. Curr Mol Med. 2008
Jun;8(4):247-52.
8. Graff LA, Walker JR, Bernstein CN. Depression and
anxiety in inflammatory bowel disease: a review of
comorbidity and management. Inflamm Bowel Dis. 2009
Jul;15(7):1105-18.
9. Mikocka-Walus AA, Turnbull DA, Moulding NT,
Wilson IG, Andrews JM, Holtmann GJ. Controversies
surrounding the comorbidity of depression and anxi-
ety in inflammatory bowel disease patients: a literature
review. Inflamm Bowel Dis. 2007 Feb;13(2):225-34.
10. McDermott E, Mullen G, Moloney J, et al. Body image
dissatisfaction: clinical features, and psychosocial disabil-
ity in inflammatory bowel disease. Inflamm Bowel Dis.
2015 Feb;21(2):353-60.
11. McDermott E, Moloney J, Rafter N et al. The body im-
age scale: a simple and valid tool for assessing body image
dissatisfaction in inflammatory bowel disease. Inflamm
Bowel Dis. 2014 Feb;20(2):286-90.
12. Vagianos K, Bector S, McConnell J, Bernstein CN.
Nutrition assessment of patients with inflammatory
bowel disease. JPEN J Parenter Enteral Nutr. 2007 Jul-
Aug; 31(4):311-9.
13. Headstrom PD, Rulyak SJ, Lee SD. Prevalence of
and risk factors for vitamin B(12) deficiency in pa-
tients with Crohn’s disease. Inflamm Bowel Dis. 2008
Feb;14(2):217-23.
14. Gasche C, Lomer MC, Cavill I, Weiss G. Iron,
anaemia, and inflammatory bowel diseases. Gut 2004;
53:1190-1197.
15. Lindgren S, Wikman O, Befrits R, et al. Intravenous iron
sucrose is superior to oral iron sulphate for correcting
anaemia and restoring iron stores in IBD patients: A ran-
domized, controlled, evaluator-blind, multicentre study.
Scand J Gastroenterol. 2009;44(7):838-45.
16. Allison MC, Howatson AG, Torrance CJ, et al. Gas-
trointestinal damage associated with the use of non-
steroidal antiinflammatory drugs. N Engl J Med. 1992
Sep;327:749-754.
17. Kaufmann HJ, Taubin HL. Nonsteroidal anti-inflamma-
tory drugs activate quiescent inflammatory bowel disease.
Ann Intern Med. 1987 Oct;107(4):513-6.
18. Gibson GR, Whitacre EB, Ricotti CA. Colitis induced
by nonsteroidal anti-inflammatory drugs. Report of four
cases and review of the literature. Arch Intern Med. 1992
Mar;152(3):625-32.
19. Higuchi LM, Khalili H, Chan AT. A prospective study
of cigarette smoking and the risk of inflammatory
bowel disease in women. Am J Gastroenterol. 2012
Sep;107(9):1399-406.
20. Birrenbach T, Böcker U. Inflammatory bowel disease and
smoking. A review of epidemiology, pathophysiology,
and therapeutic implications. Inflamm Bowel Dis. 2004
Nov;10(6):848-59.
21. Karczewski J, Poniedziałek B, Rzymski P et al. The effect
of cigarette smoking on the clinical course of inflamma-
tory bowel disease. Prz Gastroenterol. 2014;9(3):153-9.
22. Rodemann JF, Dubberke ER, Reske KA, et al. Incidence
of Clostridium difficile infection in inflammatory bowel
disease. Clin Gastroenterol Hepatol. 2007 Mar; 5(3):339-
44.
23. Issa M, Vijayapal A, Graham MB, et al. Impact of Clos-
tridium difficile on inflammatory bowel disease. Clin
Gastroenterol Hepatol. 2007 Mar; 5(3):345-51.
24. Bagdasarian N, Rao K, Malani PN. Diagnosis and
treatment of Clostridium difficile in adults: A systematic
review. JAMA. 2015 Jan; 313(4):398.
25. Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota
transplant for treatment of Clostridium difficile infection
in immunocompromised patients. Am J Gastroenterol.
2014 Jul;109(7):1065-71.